MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Tuesday, June 6, 2017

1:45pm-3:15pm
Evaluating wearable sensors for objective measurement of motor features in Parkinson disease and Huntington disease – a pilot study

J. Adams, M. Xiong, K. Dinesh, C. Tarolli, S. Sharma, N. Sheth, A.J. Aranyosi, W. Zhu, S. Goldenthal, K. Biglan, R. Dorsey, G. Sharma (Rochester, NY, USA)

Technology  ·  Exhibit Hall C
1:45pm-3:15pm
Evaluation of CSF cytokine profiles in people with Parkinson disease and age-matched controls.

G. Crotty, D. Vaughan, G. Moloney, G. O'Keeffe, S. O'Sullivan, A. Sullivan (Cork, Ireland)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Evaluation of Patient-Reported Outcomes in Tardive Dyskinesia Patients With Underlying Psychotic and Mood Disorders in the ARM-TD and AIM-TD Trials

H. Fernandez, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, K. Anderson (Cleveland, OH, USA)

Drug-Induced Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
Evaluation of serum sestrin protein in Parkinson’s disease: a plausible diagnostic marker

S. Dey, N. Rai, A. Singh, S. Shekhar, A. Dey (New Delhi, India)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Evaluation of spike sorting algorithms applied to artificial spikes and to spikes recorded from the Subthalamic Nucleus of PD patients

J. Sukiban, N. Voges, I. Weber, T. Dembek, M. Denker, M. Barbe, S. Grün, L. Timmermann (Cologne, Germany)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Evaluation of Swallowing Function in Parkinson’s Disease Patients with and without Dysphagia Complaints

E. Umay, E. Ozturk, I. Gundogdu, O. Delibas, A. Cakci, B. Gonenli, Y. Eren (Ankara, Turkey)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Evaluation of the short-term and long-term effects of an intensive multidisciplinary collective rehabilitation program over 5 weeks in Parkinson’s patients followed in Lyon

T. DANAILA, C. LAURENCIN, P. ROCHE, S. THOBOIS, M. CHEMINON, J. LUAUTE (BRON, France)

Therapy in Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)

Huntington's Disease  ·  Exhibit Hall C
1:45pm-3:15pm
Examining central cognitive processing speed as an early marker of Huntington’s disease (HD) onset

A. Nathan, S. Park, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

Huntington's Disease  ·  Exhibit Hall C
1:45pm-3:15pm
Exercise preferences of people with Parkinson’s disease: preliminary findings of a discrete choice experiment

C. Canning, C. Canning, S. Paul, J. Bampton, C. Sherrington, K. Howard (Lidcombe, Sydney, Australia)

Therapy in Movement Disorders  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 38
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley